New Video Series on the 5 Steps of the Drug Development Process and How RDCA-DAP Can Help – NORD (National Organization for Rare Disorders)
There are five steps in the drug development process, which are designed to help ensure that potential new therapies are both safe and effective. Developing medical products for rare diseases encounters many challenges throughout this process. The Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP) is being developed by NORD and the Critical Path Institute (C-Path) to Read more >
